ProfileGDS5822 / ILMN_3082206
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 70% 67% 61% 66% 70% 68% 68% 70% 64% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 148.170
GSM1276600PDAC Late Ablation Control 244.267
GSM1276601PDAC Late Ablation Control 334.861
GSM1276602PDAC Late Ablation 135.266
GSM1276603PDAC Late Ablation 257.470
GSM1276604PDAC Late Ablation 35068
GSM1303940PDAC Late Ablation_anti-CTLA4 140.968
GSM1303941PDAC Late Ablation_anti-CTLA4 266.470
GSM1303942PDAC Late Ablation_anti-CTLA4 34664